ECAM
XBI icon

East Coast Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

East Coast Asset Management’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-900
Closed -$31K – 326
2013
Q2 		$31K Buy
+900
New +$31.6K 0.02% 266

Other funds holding XBI

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PVH
Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

East Coast Asset Management's XBI Position: Q3 2013 in Review

East Coast Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2013, closing a stake of 900 shares — an estimated $31K sold.

East Coast Asset Management first reported a position in XBI in Q2 2013 and held it in 1 quarter. The position peaked at $31K in Q2 2013. 125 funds tracked by Wall St. Rank hold XBI as of Q3 2013.

  • East Coast Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2013 after selling out during the quarter.
  • East Coast Asset Management sold 900 State Street SPDR S&P Biotech ETF shares in Q3 2013, an estimated $31K.
  • East Coast Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and held it in 1 quarter.
  • East Coast Asset Management's State Street SPDR S&P Biotech ETF position peaked at $31K in Q2 2013.
  • 125 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2013.

Based on East Coast Asset Management's 13F filing for Q3 2013, filed 14 Nov 2013.